发明授权
- 专利标题： Proteosome influenza vaccine
- 专利标题（中）： 蛋白酶体流感疫苗
-
申请号： US10771737申请日： 2004-02-03
-
公开(公告)号： US07399840B2公开(公告)日： 2008-07-15
- 发明人: David S. Burt , David H. Jones , George H. Lowell , Gregory L. White , Kirkor Torossian , Louis F. Fries, III , Martin Plante
- 申请人： David S. Burt , David H. Jones , George H. Lowell , Gregory L. White , Kirkor Torossian , Louis F. Fries, III , Martin Plante
- 申请人地址： CA Laval
- 专利权人： ID Biomedical Corporation of Quebec
- 当前专利权人： ID Biomedical Corporation of Quebec
- 当前专利权人地址： CA Laval
- 代理机构： Seed IP Law Group PLLC
- 主分类号： A23J1/00
- IPC分类号： A23J1/00
摘要：
Improved forms of vaccines which comprise proteosomes and protein antigens are described. Vaccines which contain influenza HA as the antigen are used for illustration as to demonstrate efficacy. Improvements in the preparation of the vaccines themselves and the proteosome component are also included.
公开/授权文献
- US20040156867A1 Proteosome influenza vaccine 公开/授权日：2004-08-12
信息查询
